Solesence, Inc. Common Stock logo

Solesence, Inc. Common Stock

SLSN

NASDAQConsumer DefensiveHousehold & Personal Products

Latest quote

$0.95

−$0.0407 · -4.11%

Aug 21, 3:55 PM ET

SLSN company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

75

Undervalued

Momentum

19

Strong Down

Sentiment

50

Mixed

Risk resilience

23

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.

Industry
Household & Personal Products
Sector
Consumer Defensive
Headquarters
US
CEO
Kevin Cureton
Listed since
Nov 26, 1997
Employees
115

Market position

Volume
11.83K
0.14× average
Average volume
82.11K
Average daily volume
Market cap
67.1M USD
Beta
1.26
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
135.58M USD
EV / EBITDA
36.73×
Earnings yield
1.59%
Free cash flow yield
-9.52%

Profitability & efficiency

Return on equity
10.15%
Return on assets
3.58%
Return on invested capital
3.58%

Financial health

Current ratio
2.07×
Altman Z-score
-0.8
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends35%18%1%-16%Gross margin, FY2021: 29.48%Gross margin, FY2022: 22.40%Gross margin, FY2023: 20.98%Gross margin, FY2024: 30.92%Gross margin, FY2025: 25.82%Operating margin, FY2021: 8.68%Operating margin, FY2022: -6.05%Operating margin, FY2023: -9.51%Operating margin, FY2024: 9.80%Operating margin, FY2025: 2.53%Net margin, FY2021: 7.87%Net margin, FY2022: -7.03%Net margin, FY2023: -11.77%Net margin, FY2024: 8.09%Net margin, FY2025: 2.88%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 29.48%. Gross margin FY2022 22.40%. Gross margin FY2023 20.98%. Gross margin FY2024 30.92%. Gross margin FY2025 25.82%. Operating margin FY2021 8.68%. Operating margin FY2022 -6.05%. Operating margin FY2023 -9.51%. Operating margin FY2024 9.80%. Operating margin FY2025 2.53%. Net margin FY2021 7.87%. Net margin FY2022 -7.03%. Net margin FY2023 -11.77%. Net margin FY2024 8.09%. Net margin FY2025 2.88%.

Income trends

Revenue

62.06M USD+18.56%

Operating income

1.57M USD-69.37%

Net income

1.79M USD-57.73%
Income trends across reported periods68.71M USD42.13M USD15.55M USD−11.04M USDRevenue, FY2021: 29.48M USDRevenue, FY2022: 37.32M USDRevenue, FY2023: 37.3M USDRevenue, FY2024: 52.35M USDRevenue, FY2025: 62.06M USDOperating income, FY2021: 2.56M USDOperating income, FY2022: −2.26M USDOperating income, FY2023: −3.55M USDOperating income, FY2024: 5.13M USDOperating income, FY2025: 1.57M USDNet income, FY2021: 2.32M USDNet income, FY2022: −2.62M USDNet income, FY2023: −4.39M USDNet income, FY2024: 4.24M USDNet income, FY2025: 1.79M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 29.48M USD. Revenue FY2022 37.32M USD. Revenue FY2023 37.3M USD. Revenue FY2024 52.35M USD. Revenue FY2025 62.06M USD. Operating income FY2021 2.56M USD. Operating income FY2022 −2.26M USD. Operating income FY2023 −3.55M USD. Operating income FY2024 5.13M USD. Operating income FY2025 1.57M USD. Net income FY2021 2.32M USD. Net income FY2022 −2.62M USD. Net income FY2023 −4.39M USD. Net income FY2024 4.24M USD. Net income FY2025 1.79M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue62.06M USD52.35M USD37.3M USD37.32M USD29.48M USD
Cost of goods sold46.04M USD36.16M USD29.47M USD28.96M USD20.79M USD
Gross profit16.03M USD16.19M USD7.83M USD8.36M USD8.69M USD
Research and development4.08M USD3.84M USD3.84M USD3.04M USD2.24M USD
Selling, general, and administrative10.38M USD7.22M USD7.53M USD7.58M USD3.9M USD
Operating expenses14.46M USD11.06M USD11.37M USD10.62M USD6.13M USD
Interest expense931K USD670K USD838K USD382K USD1.15M USD
Depreciation and amortization897K USD928K USD742K USD567K USD454K USD
Operating income1.57M USD5.13M USD−3.55M USD−2.26M USD2.56M USD
Net income1.79M USD4.24M USD−4.39M USD−2.62M USD2.32M USD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.080.03-0.01-0.06Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 13, 2024: actual 0.04, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual -0.008, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 5, 2025: actual 0.001, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 31, 2025: actual 0.04, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 11, 2025: actual -0.02, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 0.002, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 12, 2026: actual -0.01, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 19, 2026: actual -0.002, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates21.17M18.01M14.84M11.67MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 13, 2024: actual 16.87M USD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual 12.57M USD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 5, 2025: actual 14.63M USD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 31, 2025: actual 20.36M USD, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 11, 2025: actual 14.6M USD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 12.48M USD, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 12, 2026: actual 12.96M USD, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 19, 2026: actual 15.33M USD, estimate —, surprise —, Comparison unavailable.

ETFs holding SLSN

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research SLSN

research.disclaimer